Phase 4 Immunodeficiency Clinical Trials
9 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–9 of 9 trials
Recruiting
Phase 4
Using Multiphase Optimization Strategy (MOST) to Optimize a Cost-effective, Sustainable and Scalable Smoking Cessation Package for Smokers in HIV Clinical Care
Smoking CessationHuman Immunodeficiency Virus (HIV)
New York University500 enrolled1 locationNCT06598397
Recruiting
Phase 4
Low Dose Naltrexone for Pain in Patients With HIV
Human Immunodeficiency VirusChronic Neuropathic Pain
Emory University60 enrolled3 locationsNCT05537935
Recruiting
Phase 4
A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV
Human Papilloma VirusHPVHuman Immunodeficiency Virus
University of British Columbia275 enrolled10 locationsNCT05495906
Recruiting
Phase 4
An Open-label, Multicenter Study to Assess the Pharmacokinetics (PK), Safety, and Tolerability of Subcutaneous IgPro20 in Immunoglobulin (IG) Treatment-naïve Participants With Primary Immunodeficiency (PID)
Primary Immunodeficiency
CSL Behring8 enrolled8 locationsNCT07076446
Recruiting
Phase 4
Clozapine-related Immunodeficiency in Parkinsons Disease
ImmunodeficiencyPsychosisParkinson's Disease (PD)+1 more
Centre Hospitalier Universitaire, Amiens24 enrolled1 locationNCT06634641
Recruiting
Phase 4
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
Papillomavirus InfectionHuman Immunodeficiency VirusCervical Intraepithelial Neoplasia+4 more
Louisiana State University Health Sciences Center in New Orleans250 enrolled1 locationNCT05266898
Recruiting
Phase 4
Usage of Spirometry in Managing IgG Therapy in CVID with Airway Disease
Common Variable Immunodeficiency
University of Alabama at Birmingham22 enrolled1 locationNCT05193552
Active
Phase 4
A randomised open-label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2-3 nucleoside reverse transcriptase inhibitors (NRTI) backbone versus ritonavir boosted lopinavir and raltegravir in participants virologically failing first-line non-nucleoside reverse transcriptase inhibitors (NNRTI)/2 NRTI therapy (the SECOND-LINE study). This study is for Human Immunodeficiency Virus (HIV) infection.
Human Immunodeficiency Virus (HIV) -1 infection
University of New South Wales/Kirby Institute550 enrolled31 locationsACTRN12609000881235
Completed
Phase 4
Cardiovascular function with switching from Kivexa to Truvada (or from Abacavir to Tenofovir).
Human Immunodeficiency Virus (HIV)Cardiovascular function
St Vincents Hospital20 enrolled1 locationACTRN12609000014257